Patent ID: 11930836
Assignee: SOCIETE DES PRODUITS NESTLE S.A.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 0:
1. A method to promote, support or optimise de novo myelination, in particular the de novo myelination trajectory, and/or brain structure, and/or brain connectivity, and/or intellectual potential and/or cognitive potential and/or learning potential and/or cognitive functioning in a formula fed subject in need thereof, the method comprising administering a synthetic nutritional composition comprising a fatty acid derivative to the formula fed subject, wherein the brain structure refers to the amount and/or spatial distribution of myelinated matter throughout the brain, and/or in specific brain regions, the cognitive function is optimised if the formula fed subject's scores in a standardized neurodevelopmental test are less than one standard deviation different from that of an exclusively breastfed subject of a well-nourished mother, and the fatty acid derivative is selected from the group consisting of a free fatty acid, a monoacylglycerol, a diacylglycerol, a triacylglycerol, a cholesterol ester, and combinations thereof and comprises at least one of docosahexaenoic acid, arachidonic acid, nervonic acid, or stearic acid.